LOOP/LPPPF LoopShare Ltd.
Inspired by the 1970's Choom Gang
CSE: #CHOO OTC: #CHOOF Choom is all about cultivating good times with good friends. At every Choom retail location, you'll be sure to find some of the best varieties, sourced from Health Canada approved Licensed Producers, curated to cater to a wide range of users- from the cannabis curious to the seasoned consumer.
Say hello to Choom™
$CTXR #BREAKING #NEWS #CitiusPharmaceuticals to Present at the 2016 Aegis Growth Conference CRANFORD, N.J., Sept. 19, 2016 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") CTXR, +3.23% a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its President and CEO, Myron Holubiak, will present at the 2016 Aegis Growth Conference. The Conference will be held on September 20-22, 2016 at the Encore at Wynn Las Vegas.
Event: 2016 Aegis Growth Conference
Location: The Encore at Wynn Las Vegas
Date: Wednesday, September 21, 2016
Time: 10:00 AM (PST) in Brahms 4
Webcast:
Mr. Holubiak will deliver the Company's corporate presentation and discuss recent business highlights. Mr. Holubiak will also be available for one-on-one meetings. To arrange a meeting with management, please contact Andrew Scott at [email protected].
About Citius Pharmaceuticals, Inc.
Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives, cancer care and unique prescription products using innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. We seek to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, we seek to reduce the risks associated with pharmaceutical product development and regulatory requirements. We focus on developing products that have intellectual property protection and competitive advantages to existing therapeutic approaches. www.citiuspharma.com
Safe Harbor
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations an
Sample Preparation using PCT from #PBIO
$PBIO #Discovery Starts With Sample Preparation using PCT from #PBIO
#PBIO $$2 Back to Back $500,000.00 Quarters (Retired Debt) Up Listing Immanent to Nasdaq, CEO Interview: Richard Schumacher of #PBIO w/ #TheStreet.com #Analyst John Persinos
OTC WATCH GETS REVAMPED (VISIT,REGISTER,FREE,TODAY)
OTC WATCH (Gets a new look)
'Built by Traders 4 Traders'
Fastest Growing - Social Media 4 Traders
Visit-Register-Free-Today
https://otc.watch/?mref=ipoguy
